Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Statement

16 Apr 2019 07:00

RNS Number : 2537W
Kainos Group plc
16 April 2019
 

16 April 2019

Kainos Group plc

("Kainos" or "the Company")

Trading Update

 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the year ended 31 March 2019. Trading in the period has continued in line with market expectations, as updated following the trading statement dated 4 February 2019 and the Company remains well positioned in its core markets, underpinned by a strong sales performance.

Growth in Digital Services has been strong, driven by both Digital Transformation and Workday Services, and with continued momentum across government, commercial and healthcare clients. The international client base has also continued to expand, supported by the Group's broadened European and North American footprint.

Digital Platforms has performed in line with expectations, mainly driven by the Kainos Smart platform, where we have continued to acquire new national and international clients.

Recruitment remains strong, with the total number of employees and contractors worldwide at the end of March 2019 at 1,470, an increase of 301 people since 1 April 2018.

Kainos has a robust balance sheet with no debt and strong cash generation.

Kainos will announce results for the year ended 31 March 2019 on Tuesday 28 May 2019.

- ENDS-

 

 For further information, please contact:

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Peter McKeown, Deputy Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS.

Kainos employs approximately 1,470 staff and contractors across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFEFIIFUSELL
Date   Source Headline
23rd Aug 20183:40 pmRNSTotal Voting Rights
8th Aug 20182:21 pmRNSDirector/PDMR Shareholding
8th Aug 20182:20 pmRNSDirector/PDMR Shareholding
31st Jul 20183:00 pmRNSAnnual Report and Notice of AGM
24th Jul 20185:41 pmRNSTotal Voting Rights
24th Jul 20183:57 pmRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 20184:51 pmRNSKainos Director/PDMR Shareholding
3rd Jul 201811:54 amRNSKainos Director/PDMR Shareholding
26th Jun 20187:00 amRNSCapital Markets Day
25th Jun 20181:17 pmRNSDirector's Declaration
29th May 20187:00 amRNSPreliminary Results
24th May 20183:08 pmRNSBoard Committee Membership
16th Apr 20187:25 amRNSTrading Update
23rd Mar 20181:06 pmRNSNotification Of Major Holding(s)
23rd Mar 20189:00 amRNSDirector Declaration
22nd Mar 20185:45 pmRNSHolding(s) in Company
23rd Jan 20188:00 amRNSKainos advances digital healthcare transformation
27th Nov 20177:00 amRNSInterim Results
24th Oct 20178:00 amRNSKainos expands its Workday operations in Europe
28th Sep 201711:32 amRNSResult of AGM
4th Sep 20177:00 amRNSTrading Update
17th Aug 20174:32 pmRNSHolding(s) in Company
31st Jul 20173:08 pmRNSAnnual Report 2017 and Notice of AGM
11th Jul 201711:01 amRNSDirector/PDMR shareholdings
6th Jul 20177:00 amRNSFirst Irish customer for Kainos Evolve
3rd Jul 20174:29 pmRNSDirector/PDMR Shareholding
29th Jun 201712:33 pmRNSHolding(s) in Company
30th May 20177:00 amRNSPreliminary Results
12th Apr 20177:00 amRNSTrading Update
27th Mar 201712:01 pmRNSHolding(s) in Company
6th Mar 201710:00 amRNSKainos expands its Workday services in Europe
28th Nov 20167:00 amRNSInterim Results
14th Nov 20167:00 amRNSAppointment of Joint Corporate Broker
2nd Nov 20167:00 amRNSNotice of Results
22nd Sep 20161:45 pmRNSResult of AGM
6th Sep 20167:00 amRNSTrading Update
29th Jul 20165:00 pmRNSAnnual Report 2016 and Notice of AGM
21st Jul 20165:47 pmRNSAward of Shares under SIP and Directors' Dealings
30th Jun 20165:10 pmRNS2016 LTIP Awards - Replacement
30th Jun 20164:25 pmRNS2016 LTIP Awards
13th Jun 20162:27 pmRNSDirector/PDMR Shareholding
9th Jun 20168:00 amRNSKainos appoints new Commercial Client Director
31st May 20167:00 amRNSPreliminary Results
3rd May 20167:00 amRNSNotice of Results
19th Apr 20167:00 amRNSCapital Markets Day
31st Mar 20164:11 pmRNSDirector/PDMR Shareholding
16th Mar 20167:01 amRNSKainos Evolve and InTouch Health Partnership
16th Mar 20167:00 amRNSTrading Update
8th Mar 20161:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.